Ego Pharmaceuticals Pty Ltd in Consumer Health (Australia)

April 2014 | 2 pages | ID: ECBCE9C92E5EN
Euromonitor International Ltd

Abstracts

Ego Pharmaceuticals will continue to reinforce its dominant position in Australia while focusing on expansion within the Asia-Pacific region, the Middle East and the UK to drive additional value growth. To improve productivity and storage capacity the company has invested in the upgrading of its technology systems and software.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
Summary 1 Ego Pharmaceuticals Pty Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 2 Ego Pharmaceuticals Pty Ltd : Competitive Position 2013